Tony Medrano - AI, Peptides, and the Future of Personalized Longevity

In this episode of _Data Day with Greg Michaelson_, Greg sits down with Tony Medrano to explore the rapidly evolving intersection of AI, wearable health data, peptides, and personalized longevity optimization. Tony shares his journey from founding one of the earliest AI startups in 2016 to helping scale a molecular diagnostics company from zero to $1 billion in revenue during the COVID era, serving organizations like NASA, Google, the NFL, and the NBA.  The conversation dives deep into: What peptides actually are and how they work The science behind compounds like BPC-157, GHK-CU, MOTS-c, and tesamorelin AI-driven “digital twin” health optimization Wearables, HRV tracking, and personalized biometric analysis The difference between supplements, peptides, and pharmaceutical drugs Longevity strategies for athletes, executives, and people over 40 Why most longevity advice online is noisy, biased, or incomplete The future of AI-powered health coaching and preventative medicine Tony also explains how Longevity Plan AI combines wearable data, peptide protocols, physician oversight, and AI modeling to create personalized health optimization plans designed to improve recovery, metabolic health, energy, sleep, and performance.  If you’re interested in biohacking, longevity, AI-driven healthcare, performance optimization, or the future of personalized medicine, this episode is packed with fascinating insights and practical discussion.